Literature DB >> 16712568

Omenn syndrome: therapeutic effects of cyclosporin.

Sylvan Rego1, Andrew Kemp, Melanie Wong, Paul Knight.   

Abstract

Omenn syndrome is a severe combined immunodeficiency with features of generalised erythroderma alopecia and evidence of Th2 inflammation (eosinophilia and raised IgE). We describe a differential effect of 2 calcineurin inhibitors, cyclosporine A (CsA) and tacrolimus, with CsA rapidly improving the erythroderma and lymphocytosis but tacrolimus having little effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712568     DOI: 10.1111/j.1440-1754.2006.00863.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  Acquired Omenn-like syndrome, a novel posttransplant autoaggression syndrome reversed by rapamycin.

Authors:  Donald C Vinh; Khalid Bin Dhuban; Helen Mason; Duncan Lejtenyi; Sungmi Jung; Donald C Sheppard; Damien Faury; Nada Jabado; Ciriaco A Piccirillo
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

2.  Selective clinical and immune response of the oligoclonal autoreactive T cells in Omenn patients after cyclosporin A treatment.

Authors:  A Lev; A J Simon; N Amariglio; G Rechavi; R Somech
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.